NCT04846647View on ClinicalTrials.gov

Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of Hypophosphatemia

CompletedOBSERVATIONAL

Enrollment

260

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions

Hypophosphatemia Without Immediate AnteriorityUnexplained Hypophosphatemia

Interventions

BEHAVIORAL

unexplained hypophoshatemia

Collection of additional blood volume (approximately 10 mL) during blood tests provided as part of the usual medical care.

Trial Locations (2)

63003

Chu Clermont Ferrand, Clermont-Ferrand

Unknown

Centre Jean Perrin, Clermont-Ferrand

All Listed Sponsors

collaborator

DiaSorin ; Saluggia, Italia

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT04846647 - Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of Hypophosphatemia | Biotech Hunter | Biotech Hunter